Drug firm Unichem Laboratories has received Establishment Inspection Report (EIR) from the US health regulator for the company's plant at Goa.
The company's formulations manufacturing facility at Goa has received an EIR from the United States Food and Drug Administration (USFDA), Unichem Laboratories said in a BSE filing today.
This receipt indicates successful closure of the inspection and queries raised during the audit, it added.
The inspection that was carried out between March 14-20, 2017 has now been closed by the regulator, the company said.
Shares of Unichem Laboratories were today trading 2.10 per cent higher at Rs 265.55 per scrip on BSE.
Disclaimer: No Business Standard Journalist was involved in creation of this content
